The New Era in DTC: FDA Plans New Fees, Fines-and Creative Advice
This article was originally published in RPM Report
Executive Summary
The new FDA law marks a turning point in the relatively short history of direct-to-consumer broadcast ads. Sponsors have preserved the right to advertise, but will have to get used to following FDA's schedule-and taking FDA's advice.